Advertisement
OtherBehavioral Pharmacology

Role of Efficacy as a Determinant of Locomotor Activation by Mu Opioid Receptor Ligands in Female and Male Mice

Edna J. Santos, Matthew L. Banks and S Stevens Negus
Journal of Pharmacology and Experimental Therapeutics April 30, 2022, JPET-AR-2021-001045; DOI: https://doi.org/10.1124/jpet.121.001045

Article Information

JPET-AR-2021-001045
DOI 
https://doi.org/10.1124/jpet.121.001045
PubMed 
35489781
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online April 30, 2022.
Copyright & Usage 
Copyright © 2020 American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Edna J. Santos1,
  2. Matthew L. Banks1, and
  3. S Stevens Negus1,*
  1. 1Pharmacology and Toxicology, Virginia Commonwealth University, United States
  1. ↵* Corresponding Author:
    S Stevens Negus, Pharmacology and Toxicology, Virginia Commonwealth University, 410 N. 12th St, Richmond, Virginia, 23298, United States. E-mail: sidney.negus{at}vcuhealth.org

Statistics from Altmetric.com

Article usage

Article usage: April 2022 to May 2022

AbstractFullPdf
Apr 20222902
May 2022109063

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

OtherBehavioral Pharmacology

Efficacy as a determinant of hyperlocomotion by MOR ligands

Edna J. Santos, Matthew L. Banks and S Stevens Negus
Journal of Pharmacology and Experimental Therapeutics April 30, 2022, JPET-AR-2021-001045; DOI: https://doi.org/10.1124/jpet.121.001045
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo

Jump to section

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Advertisement